• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Dems to drop Medicare chief Berwick

Dems to drop Medicare chief Berwick

March 7, 2011 By MassDevice staff

Dr. Donald Berwick

Dr. Donald Berwick

MASSDEVICE ON CALL — Democratic senators and the White House are backing down from the controversial nomination of Dr. Donald Berwick to lead the Centers for Medicare and Medicaid Services, after running into a buzzsaw of vociferous Republican opposition.

President Barack Obama tapped Berwick last year for the top Medicare spot with a recess appointment that angered GOP members eager to score political points in a confirmation hearing. Berwick was due for re-confirmation hearings that were sure to be contentious, with Republicans taking him to task for his avowed admiration of the British healthcare system.

A "person familiar with the situation" told Politico.com that the writing on the wall became clear after 42 Republican senators — two more than the 40 votes needed to veto Berwick’s impending confirmation — sent a letter to Obama last week, asking him to withdraw Berwick’s nomination to lead the Centers for Medicare & Medicaid Services.

The Politico source said Dems and the Obama administration "can do the arithmetic" now that it’s a mathematical impossibility for Berwick’s nomination to win 60 Senate votes. That leaves him as a lame duck through 2011, but still charged with implementing the beginning stages of Obama’s landmark healthcare reform law.

Democratic Senate Finance Committee aides told healthcare lobbyists March 4 that the nomination is DOA, the confirmation hearing is off and they’re already considering "next steps," according to the website.

Scientists discover heart attack genes

Researchers have discovered 13 new genes liked with heart attack and confirmed 10 others as presaging a risk for developing heart disease, according to Reuters.

"With such information we should be able to better identify people at high risk early on in life and quickly take the steps to neutralize that excess risk," said researcher Themistocles Assimes of Stanford University School of Medicine. "Although we are inching closer to that day, we will probably need to reliably identify many more variants … over the next few years before it becomes useful to perform this genetic profiling in a doctor’s office."

An international consortium analyzed data from 14 " genome-wide association" studies of human genetic profiles for more than 22,000 people of European descent with coronary heart disease or a heart attack history. They compared those data with that from 60,000 healthy people, making it the largest genome association study ever.

HHS offers states $3.7 billion for Medicaid alternatives

The U.S. Dept. of Health and Human Services is making billions in new cash for states to provide alternatives to long-term care for Medicaid patients — a 6 percent increase in federal matching funds for the services.

The total pool is $3.7 billion, according to the American Medical Assn., contingent on the states developing plans for individuals receiving care to remain independent.

"There is more evidence than ever that people who need long-term care prefer to live in their own homes and communities whenever possible," according to outgoing CMS chief Berwick.

Findings indicate Alzheimer’s starts in liver, not brain

The plaques linked to Alzheimer’s disease start in the liver, not the brain, according to scientists from the Scripps Research Institute and ModGene LLC.

Writing in The Journal of Neuroscience Research, the researchers reporting discovering
three genes that protected mice from developing protein deposits in the brain associated with Alzheimer’s.

They hypothesize that the proteins originate in the liver and travel through the bloodstream to enter the brain. That opens to door to potential treatments that would block the protein from entering the brain.

The lung cancer-toenails link

Men with high levels of nicotine in their toenails were about 3.5 times more likely to develop lung cancer than those with lower levels regardless of their smoking historie., according to a study in the American Journal of Epidemiology.

Researchers examined data from 33,737 men dating back to 1986. Their findings suggest that the long-term consequences of smoking may be underestimated.

Filed Under: Healthcare Reform, News Well

In case you missed it

  • Abbott imaging catheter recall flagged as Class I by FDA
  • Will Johnson & Johnson buy Boston Scientific?
  • Needham & Co. downgrades Medtronic, Zimmer Biomet shares
  • DoMore Diagnostics wins CE mark for AI algorithm that predicts colorectal cancer outcomes
  • Quidel, Ortho Clinical Diagnostics combine to form in vitro diagnostics company
  • Zimmer Biomet adds ESG and CEO visibility to executive’s duties
  • U of Maryland scientist to set up NIH’s new Advanced Research Projects Agency for Health
  • ‘Catastrophic explosion’ and resin shortage led Medtronic’s supply chain problems
  • FDA grants IDE for MedAlliance’s sirolimus-eluting balloon
  • Medtronic ‘hopeful’ on FDA clearance for next-gen diabetes tech in FY 2023
  • Bigfoot Biomedical adds former Insulet VP as chief commercial officer
  • Medtronic, DaVita to form new kidney care company
  • Medtronic stock down on Q4 earnings miss
  • 3M Health Care Business president is leaving this year
  • Device developer SeaStar Medical hires chief medical officer
  • AccuPulse raises $10M Series A
  • Exactech announces first U.S. surgeries with its nex-gen laser cage glenoid

RSS From Medical Design & Outsourcing

  • Download COMSOL News Special Edition Biomedical
    Get instant access to this special edition of COMSOL News where you will read user stories that showcases how simulation enables engineers, researchers, and scientists explore and analyze biomedical designs. Download Now.       The post Download COMSOL News Special Edition Biomedical appeared first on Medical Design and Outsourcing.
  • Qosina adds new tube-to-tube barb connectors
    Qosina has added 25 new tube-to-tube barb connectors to its portfolio, the OEM single-use component supplier for the medical and pharmaceutical industries said this week. Ronkonkoma, New York-based Qosina said its inventory of tube-to-tube barb connectors is available in more than 500 configurations. The connectors can fit inner tube diameters between 1/32 in and 1… […]
  • Abbott imaging catheter recall flagged as Class I by FDA
    The FDA has identified the Abbott (NYSE:ABT) recall of its Dragonfly OpStar Imaging Catheter as a Class I recall. That’s the most serious level of a medical device recall, carrying the risk of serious injury or death. Five incidents, one injury and zero deaths were reported when Abbott initiated the recall on April 11. The… […]
  • Zimmer Biomet adds ESG and CEO visibility to executive’s duties
    Zimmer Biomet (NYSE:ZBH) today announced additional responsibilities for Investor Relations SVP and Chief Communications Officer Keri Mattox. Mattox’s new title at the Warsaw, Indiana-based orthopedics company is chief communications and administration officer. She will be responsible for “building and executing a comprehensive strategy around Environmental, Social and Governance (ESG) initiatives and increasing CEO visibility, engagement… […]
  • ‘Catastrophic explosion’ and resin shortage led Medtronic’s supply chain problems
    Medtronic CEO Geoff Martha today said a “catastrophic explosion” in Medtronic’s supply chain for packaging and a shortage of resins were the biggest issues hurting the company’s fourth-quarter performance. Fridley, Minnesota-based Medtronic (NYSE:MDT) reported about $350 million less in sales than analysts were expecting for the quarter, which ended April 29. Martha said about 75%… […]
  • 3M Health Care Business president is leaving this year
    3M Health Care Business Group President Mojdeh Poul will retire from the company on July 1, 2022. Poul joined Maplewood, Minnesota-based 3M (NYSE:MMM) in 2011 as the global business VP of critical and chronic care solutions. She later became VP and general manager of the company’s food safety business and president of numerous 3M divisions,… […]
  • Iterative Scopes announces positive data in Skout AI colonoscopy algorithm clinical trial
    Iterative Scopes this week announced positive trial data in a study of its colorectal cancer screening algorithm, Skout. Cambridge, Massachusetts-based Iterative Scopes designed Skout as a computer-aided device (CADe) that uses artificial intelligence and computer vision technology to detect suspicious tissue and provide real-time feedback for gastroenterologists performing the procedure. Get the full story on… […]
  • Device developer SeaStar Medical hires chief medical officer
    SeaStar Medical has hired Dr. Kevin Chung as chief medical officer of the medtech developer starting July 1. Denver-based SeaStar is developing a platform therapy focused on hyperinflammation of vital organs. The company’s Selective Cytopheretic Device was designated as a breakthrough device by the FDA earlier this year. SeaStar is set to go public in… […]
  • Varta presents microbattery product portfolio at Computex 2022
    Varta will present its broad product portfolio of microbatteries, which make a wide range of future-proof applications possible, at Computex in Taipei starting today. Varta’s microbattery product portfolio ranges from rechargeable lithium-ion button cells to nickel metal hydride button cells, primary silver oxide cells, primary lithium button cells and cylindrical lithium batteries to hydrogen gas… […]
  • Entegris opens Life Sciences Technology Center in Massachusetts
    Entegris (Nasdaq:ENTG) announced today that it opened a new Life Sciences Technology Center in Billerica, Massachusetts. The new Life Sciences Technology Center was built to offer life sciences customers the opportunity to leverage Entegris’ cold-chain supply expertise to optimize processes, reduce costs and increase speed to market. Get the full story at our sister site,… […]
  • MedAcuity hires SVP of business development
    Medtech software development firm MedAcuity today said it has hired Simon Johnson as SVP of business development. Westford, Massachusetts-based MedAcuity said Johnson previously built the client partner team and managed strategic clients at digital consultancy Mobiquity. He also served as SVP of client services at GreenPages Technologies, responsible for driving services revenue growth leading to… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS